Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Pneumatic Compression in Venous Thromboprophylaxis.

Elliott CG, Orme J Jr, Weaver LK.

N Engl J Med. 2019 Jul 4;381(1):94. doi: 10.1056/NEJMc1905933. No abstract available.

PMID:
31269375
2.

United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications.

Elliott CG, Austin ED, Badesch D, Badlam J, Benza RL, Chung WK, Farber HW, Feldkircher K, Frost AE, Poms AD, Lutz KA, Pauciulo MW, Yu C, Nichols WC.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019851696. doi: 10.1177/2045894019851696.

3.

Real-World Data for Pulmonary Arterial Hypertension.

Elliott CG.

Chest. 2019 Apr;155(4):653-654. doi: 10.1016/j.chest.2019.01.031. No abstract available.

PMID:
30955564
4.

Device-measured physical activity, sedentary behaviour and cardiometabolic health and fitness across occupational groups: a systematic review and meta-analysis.

Prince SA, Elliott CG, Scott K, Visintini S, Reed JL.

Int J Behav Nutr Phys Act. 2019 Apr 2;16(1):30. doi: 10.1186/s12966-019-0790-9.

5.

Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.

Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE, McGoon MD, Pasta DJ, Selej M, Burger CD, Frantz RP.

Chest. 2019 Aug;156(2):323-337. doi: 10.1016/j.chest.2019.02.004. Epub 2019 Feb 14.

6.

Chronic Thromboembolic Pulmonary Hypertension Cases Cluster in Families.

Dodson MW, Allen-Brady K, Brown LM, Elliott CG, Cannon-Albright LA.

Chest. 2019 Feb;155(2):384-390. doi: 10.1016/j.chest.2018.10.004.

PMID:
30732691
7.

Therapy for Pulmonary Arterial Hypertension in Adults: Update of the CHEST Guideline and Expert Panel Report.

Klinger JR, Elliott CG, Levine DJ, Bossone E, Duvall L, Fagan K, Frantsve-Hawley J, Kawut SM, Ryan JJ, Rosenzweig EB, Sederstrom N, Steen VD, Badesch DB.

Chest. 2019 Mar;155(3):565-586. doi: 10.1016/j.chest.2018.11.030. Epub 2019 Jan 17.

PMID:
30660783
8.

Periostin and CCN2 Scaffolds Promote the Wound Healing Response in the Skin of Diabetic Mice.

Elliott CG, Wang J, Walker JT, Michelsons S, Dunmore-Buyze J, Drangova M, Leask A, Hamilton DW.

Tissue Eng Part A. 2019 Sep;25(17-18):1326-1339. doi: 10.1089/ten.TEA.2018.0268. Epub 2019 Feb 27.

PMID:
30572781
9.

Genetics and genomics of pulmonary arterial hypertension.

Morrell NW, Aldred MA, Chung WK, Elliott CG, Nichols WC, Soubrier F, Trembath RC, Loyd JE.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801899. doi: 10.1183/13993003.01899-2018. Print 2019 Jan.

10.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.

11.

Response.

Frantz RP, Zhao C, Farber HW, Badesch DB, Elliott CG, Frost AE, McGoon MD, Mink DR, Selej M, Benza RL.

Chest. 2018 Nov;154(5):1262-1264. doi: 10.1016/j.chest.2018.07.033. No abstract available.

PMID:
30409362
12.

Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.

Nikolic I, Yung LM, Yang P, Malhotra R, Paskin-Flerlage SD, Dinter T, Bocobo GA, Tumelty KE, Faugno AJ, Troncone L, McNeil ME, Huang X, Coser KR, Lai CSC, Upton PD, Goumans MJ, Zamanian RT, Elliott CG, Lee A, Zheng W, Berasi SP, Huard C, Morrell NW, Chung RT, Channick RW, Roberts KE, Yu PB.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):891-902. doi: 10.1164/rccm.201807-1236OC.

PMID:
30312106
13.

The effectiveness of eHealth interventions on physical activity and measures of obesity among working-age women: a systematic review and meta-analysis.

Cotie LM, Prince SA, Elliott CG, Ziss MC, McDonnell LA, Mullen KA, Hiremath S, Pipe AL, Reid RD, Reed JL.

Obes Rev. 2018 Oct;19(10):1340-1358. doi: 10.1111/obr.12700. Epub 2018 Aug 28.

PMID:
30156044
14.

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators.

N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.

15.

Electronic alerts, comparative practitioner metrics, and education improve thromboprophylaxis and reduce venous thrombosis in community hospitals.

Woller SC, Stevens SM, Evans RS, Wray D, Christensen J, Aston VT, Wayne M, Lloyd JF, Wilson EL, Elliott CG.

Res Pract Thromb Haemost. 2018 Jun 7;2(3):481-489. doi: 10.1002/rth2.12119. eCollection 2018 Jul.

16.

Pulmonary Arterial Hypertension.

Dodson MW, Brown LM, Elliott CG.

Heart Fail Clin. 2018 Jul;14(3):255-269. doi: 10.1016/j.hfc.2018.02.003. Review.

PMID:
29966625
17.

Use of supplemental oxygen in patients with pulmonary arterial hypertension in REVEAL.

Farber HW, Badesch DB, Benza RL, Elliott CG, Frantz RP, McGoon MD, Selej M, Zhao C, Frost AE.

J Heart Lung Transplant. 2018 Aug;37(8):948-955. doi: 10.1016/j.healun.2018.03.010. Epub 2018 Mar 17.

PMID:
29653800
18.

Management of Low-Risk Pulmonary Embolism Patients Without Hospitalization: The Low-Risk Pulmonary Embolism Prospective Management Study.

Bledsoe JR, Woller SC, Stevens SM, Aston V, Patten R, Allen T, Horne BD, Dong L, Lloyd J, Snow G, Madsen T, Elliott CG.

Chest. 2018 Aug;154(2):249-256. doi: 10.1016/j.chest.2018.01.035. Epub 2018 Feb 2.

PMID:
29410163
19.

Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.

Frantz RP, Farber HW, Badesch DB, Elliott CG, Frost AE, McGoon MD, Zhao C, Mink DR, Selej M, Benza RL.

Chest. 2018 Jul;154(1):126-135. doi: 10.1016/j.chest.2018.01.009. Epub 2018 Jan 31.

PMID:
29355551
20.

Preemptive Anticoagulation in Patients With a High Pretest Probability of Pulmonary Embolism: Are Guidelines Followed?

Willoughby L, Adams DM, Evans RS, Lloyd JF, Stevens SM, Woller SC, Bledsoe JR, Aston VT, Wilson EL, Elliott CG.

Chest. 2018 May;153(5):1153-1159. doi: 10.1016/j.chest.2017.11.007. Epub 2017 Nov 15.

PMID:
29154971
21.

Impact of Workplace Physical Activity Interventions on Physical Activity and Cardiometabolic Health Among Working-Age Women: A Systematic Review and Meta-Analysis.

Reed JL, Prince SA, Elliott CG, Mullen KA, Tulloch HE, Hiremath S, Cotie LM, Pipe AL, Reid RD.

Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2). pii: e003516. doi: 10.1161/CIRCOUTCOMES.116.003516. Epub 2017 Feb 22. Review.

PMID:
28228457
22.

EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.

Best DH, Sumner KL, Smith BP, Damjanovich-Colmenares K, Nakayama I, Brown LM, Ha Y, Paul E, Morris A, Jama MA, Dodson MW, Bayrak-Toydemir P, Elliott CG.

Chest. 2017 Apr;151(4):821-828. doi: 10.1016/j.chest.2016.11.014. Epub 2016 Nov 22.

PMID:
27884767
23.

Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.

Chaisson NF, Dodson MW, Elliott CG.

Clin Chest Med. 2016 Sep;37(3):523-34. doi: 10.1016/j.ccm.2016.04.014. Epub 2016 Jun 30. Review.

PMID:
27514598
24.

Electronic Alerts, Comparative Practitioner Metrics, and Education Improves Thromboprophylaxis and Reduces Thrombosis.

Woller SC, Stevens SM, Evans RS, Wray DG, Christensen JC, Aston VT, Wayne MH, Lloyd JF, Wilson EL, Elliott CG.

Am J Med. 2016 Oct;129(10):1124.e17-26. doi: 10.1016/j.amjmed.2016.05.014. Epub 2016 Jun 8.

PMID:
27288858
25.

Familial Chronic Thromboembolic Pulmonary Hypertension.

Desmarais J, Elliott CG.

Chest. 2016 Apr;149(4):e99-e101. doi: 10.1016/j.chest.2015.09.017.

PMID:
27055719
26.

Use of Parenteral Prostanoids: Important Insights for CHEST Physicians.

Elliott CG.

Chest. 2016 Mar;149(3):615-6. doi: 10.1016/j.chest.2015.11.024. No abstract available.

PMID:
26965964
27.

Follow-up of Incidental Pulmonary Nodules and the Radiology Report.

Blagev DP, Lloyd JF, Conner K, Dickerson J, Adams D, Stevens SM, Woller SC, Evans RS, Elliott CG.

J Am Coll Radiol. 2016 Feb;13(2 Suppl):R18-24. doi: 10.1016/j.jacr.2015.12.008.

PMID:
26846530
28.

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.

Raskob GE, Spyropoulos AC, Zrubek J, Ageno W, Albers G, Elliott CG, Halperin J, Haskell L, Hiatt WR, Maynard GA, Peters G, Spiro T, Steg PG, Suh EY, Weitz JI.

Thromb Haemost. 2016 Jun 2;115(6):1240-8. doi: 10.1160/TH15-09-0756. Epub 2016 Feb 4.

29.

Genetic Deletion of Galectin-3 Does Not Impair Full-Thickness Excisional Skin Healing.

Walker JT, Elliott CG, Forbes TL, Hamilton DW.

J Invest Dermatol. 2016 May;136(5):1042-1050. doi: 10.1016/j.jid.2016.01.014. Epub 2016 Jan 29.

30.

Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).

Woller SC, Stevens SM, Kaplan DA, Branch DW, Aston VT, Wilson EL, Gallo HM, Johnson EG, Rondina MT, Lloyd JF, Evans RS, Elliott CG.

Clin Appl Thromb Hemost. 2016 Apr;22(3):239-47. doi: 10.1177/1076029615615960. Epub 2015 Nov 12.

PMID:
26566669
31.

Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects.

Machado RD, Southgate L, Eichstaedt CA, Aldred MA, Austin ED, Best DH, Chung WK, Benjamin N, Elliott CG, Eyries M, Fischer C, Gräf S, Hinderhofer K, Humbert M, Keiles SB, Loyd JE, Morrell NW, Newman JH, Soubrier F, Trembath RC, Viales RR, Grünig E.

Hum Mutat. 2015 Dec;36(12):1113-27. doi: 10.1002/humu.22904. Epub 2015 Oct 12. Review.

32.

VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock.

Kaplan D, Casper TC, Elliott CG, Men S, Pendleton RC, Kraiss LW, Weyrich AS, Grissom CK, Zimmerman GA, Rondina MT.

Chest. 2015 Nov;148(5):1224-1230. doi: 10.1378/chest.15-0287.

33.

Five-Year outcomes of patients enrolled in the REVEAL Registry.

Farber HW, Miller DP, Poms AD, Badesch DB, Frost AE, Muros-Le Rouzic E, Romero AJ, Benton WW, Elliott CG, McGoon MD, Benza RL.

Chest. 2015 Oct;148(4):1043-54. doi: 10.1378/chest.15-0300.

34.

When to offer genetic testing for pulmonary arterial hypertension.

Chung WK, Austin ED, Best DH, Brown LM, Elliott CG.

Can J Cardiol. 2015 Apr;31(4):544-7. doi: 10.1016/j.cjca.2014.11.005. Epub 2014 Nov 11. Review.

35.

Validation of two predictive models for survival in pulmonary arterial hypertension.

Sitbon O, Benza RL, Badesch DB, Barst RJ, Elliott CG, Gressin V, Lemarié JC, Miller DP, Muros-Le Rouzic E, Simonneau G, Frost AE, Farber HW, Humbert M, McGoon MD.

Eur Respir J. 2015 Jul;46(1):152-64. doi: 10.1183/09031936.00004414. Epub 2015 Apr 2.

36.

Inflammatory microenvironment and tumor necrosis factor alpha as modulators of periostin and CCN2 expression in human non-healing skin wounds and dermal fibroblasts.

Elliott CG, Forbes TL, Leask A, Hamilton DW.

Matrix Biol. 2015 Apr;43:71-84. doi: 10.1016/j.matbio.2015.03.003. Epub 2015 Mar 14.

PMID:
25779637
37.

[Genetics and genomics of pulmonary arterial hypertension].

Soubrier F, Chung WK, Machado R, Grünig E, Aldred M, Geraci M, Loyd JE, Elliott CG, Trembath RC, Newman JH, Humbert M.

Turk Kardiyol Dern Ars. 2014 Oct;42 Suppl 1:17-28. Turkish.

38.

Computerized clinical decision support improves warfarin management and decreases recurrent venous thromboembolism.

Woller SC, Stevens SM, Towner S, Olson J, Christensen P, Hamilton S, Newman L, Mott L, Hu P, Brunisholz KD, Long Y, Lloyd J, Evans RS, Cannon W, Elliott CG.

Clin Appl Thromb Hemost. 2015 Apr;21(3):197-203. doi: 10.1177/1076029614550818. Epub 2014 Sep 16.

PMID:
25228672
39.

Genetics of pulmonary hypertension.

Best DH, Austin ED, Chung WK, Elliott CG.

Curr Opin Cardiol. 2014 Nov;29(6):520-7. doi: 10.1097/HCO.0000000000000105. Review.

PMID:
25159282
40.

Fibrinolysis for intermediate-risk pulmonary embolism.

Elliott CG.

N Engl J Med. 2014 Aug 7;371(6):582. doi: 10.1056/NEJMc1406283. No abstract available.

PMID:
25105191
41.

Robyn j. Barst, MD.

Elliott CG.

Pulm Circ. 2013 Dec;3(4):968. doi: 10.1086/674748. No abstract available.

42.

Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.

Taichman DB, Ornelas J, Chung L, Klinger JR, Lewis S, Mandel J, Palevsky HI, Rich S, Sood N, Rosenzweig EB, Trow TK, Yung R, Elliott CG, Badesch DB.

Chest. 2014 Aug;146(2):449-475. doi: 10.1378/chest.14-0793. Review.

43.

Assessment of the safety and efficiency of using an age-adjusted D-dimer threshold to exclude suspected pulmonary embolism.

Woller SC, Stevens SM, Adams DM, Evans RS, Lloyd JF, Snow GL, Bledsoe JR, Gay DZ, Patten RM, Aston VT, Elliott CG.

Chest. 2014 Dec;146(6):1444-1451. doi: 10.1378/chest.13-2386.

PMID:
24831769
44.

Fibrinolysis of pulmonary emboli--steer closer to Scylla.

Elliott CG.

N Engl J Med. 2014 Apr 10;370(15):1457-8. doi: 10.1056/NEJMe1401025. No abstract available.

PMID:
24716686
45.

Genetics and genomics of pulmonary arterial hypertension.

Soubrier F, Chung WK, Machado R, Grünig E, Aldred M, Geraci M, Loyd JE, Elliott CG, Trembath RC, Newman JH, Humbert M.

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D13-21. doi: 10.1016/j.jacc.2013.10.035. Review.

46.

Follow-up of incidental pulmonary nodules and the radiology report.

Blagev DP, Lloyd JF, Conner K, Dickerson J, Adams D, Stevens SM, Woller SC, Evans RS, Elliott CG.

J Am Coll Radiol. 2014 Apr;11(4):378-83. doi: 10.1016/j.jacr.2013.08.003. Epub 2013 Dec 6.

PMID:
24316231
47.

Genetics of pulmonary arterial hypertension.

Elliott CG.

Clin Chest Med. 2013 Dec;34(4):651-63. doi: 10.1016/j.ccm.2013.08.003. Review.

PMID:
24267296
48.

EIF2AK4 mutations in pulmonary capillary hemangiomatosis.

Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG.

Chest. 2014 Feb;145(2):231-236. doi: 10.1378/chest.13-2366.

49.

Circulating angiogenic modulatory factors predict survival and functional class in pulmonary arterial hypertension.

Malhotra R, Paskin-Flerlage S, Zamanian RT, Zimmerman P, Schmidt JW, Deng DY, Southwood M, Spencer R, Lai CS, Parker W, Channick RN, Morrell NW, Elliott CG, Yu PB.

Pulm Circ. 2013 Apr;3(2):369-80. doi: 10.4103/2045-8932.110445.

50.

Detection of galectin-3 and localization of advanced glycation end products (AGE) in human chronic skin wounds.

Pepe D, Elliott CG, Forbes TL, Hamilton DW.

Histol Histopathol. 2014 Feb;29(2):251-8. doi: 10.14670/HH-29.251. Epub 2013 Jul 26.

PMID:
23888483

Supplemental Content

Loading ...
Support Center